Accelerate Diagnostics (LTS:0H8E) Interest Expense : $-13.12 Mil (TTM As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Accelerate Diagnostics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Accelerate Diagnostics's interest expense for the three months ended in Dec. 2024 was $ -4.49 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was $-13.12 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Accelerate Diagnostics's Operating Income for the three months ended in Dec. 2024 was $ -7.93 Mil. Accelerate Diagnostics's Interest Expense for the three months ended in Dec. 2024 was $ -4.49 Mil. Accelerate Diagnostics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Accelerate Diagnostics Interest Expense Historical Data

The historical data trend for Accelerate Diagnostics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerate Diagnostics Interest Expense Chart

Accelerate Diagnostics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-15.55

-3.77

-7.74

-13.12

Accelerate Diagnostics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-2.13	-2.45	-2.59	-3.59	-4.49

Accelerate Diagnostics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-13.12 Mil.

Accelerate Diagnostics (LTS:0H8E) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Accelerate Diagnostics's Interest Expense for the three months ended in Dec. 2024 was $-4.49 Mil. Its Operating Income for the three months ended in Dec. 2024 was $-7.93 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was $49.44 Mil.

Accelerate Diagnostics's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Accelerate Diagnostics did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Accelerate Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Accelerate Diagnostics Inc (LTS:0H8E) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

AXDX:USA AXDX:Mexico 1A80:Germany

Address

3950 South Country Club Road, Suite 470, Tucson, AZ, USA, 85714

Website

https://www.acceleratediagnostics.com

Accelerate Diagnostics Inc is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Its Clinical Microbiology products include Accelerate Pheno system, Accelerate PhenoTest BC Kit, and Accelerate Arc module & BC kit. The company earns the majority of its revenue from the domestic market. The group operates as one operating segment, deriving instrument, consumable, and service revenues from customers engaged in healthcare diagnostics within the United States. Product revenue is derived from the sale or rental of instruments and sales of related consumable products. Service revenue is derived from the sale of extended service agreements.

Accelerate Diagnostics Headlines

No Headlines